Zeo ScientifiX, Inc.
🇺🇸United States
Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD)
- First Posted Date
- 2022-12-09
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- ZEO ScientifiX, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT05643729
- Locations
- 🇺🇸
Mayo Clinic, Phoenix, Arizona, United States
Zofin to Treat COVID-19 Long Haulers
- First Posted Date
- 2022-02-08
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- ZEO ScientifiX, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT05228899
- Locations
- 🇺🇸
NewportNativeMD, Newport Beach, California, United States
🇺🇸United Memorial Medical Center, Houston, Texas, United States
🇺🇸Assuta Family Medical Group, North Hollywood, California, United States
Expanded Access to Zofin for Patients With COVID-19
- Conditions
- SARS (Severe Acute Respiratory Syndrome)Acute Respiratory Distress SyndromeCovid19Corona Virus Infection
- First Posted Date
- 2020-12-08
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- ZEO ScientifiX, Inc.
- Registration Number
- NCT04657406
Zofin (Organicell Flow) for Patients With COVID-19
Phase 1
Completed
- Conditions
- Corona Virus InfectionSARSCOVID-19Acute Respiratory Distress Syndrome
- Interventions
- Biological: ZofinOther: Placebo
- First Posted Date
- 2020-05-12
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- ZEO ScientifiX, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04384445
- Locations
- 🇺🇸
George C. Shapiro, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath